KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $1.4 billion.

  • Organon's Accumulated Expenses fell 96.02% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 96.02%. This contributed to the annual value of $1.4 billion for FY2024, which is 158.39% up from last year.
  • Latest data reveals that Organon reported Accumulated Expenses of $1.4 billion as of Q3 2025, which was down 96.02% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Organon's Accumulated Expenses ranged from a high of $1.5 billion in Q3 2024 and a low of $759.0 million during Q1 2021
  • Moreover, its 5-year median value for Accumulated Expenses was $1.2 billion (2022), whereas its average is $1.2 billion.
  • Per our database at Business Quant, Organon's Accumulated Expenses skyrocketed by 5493.17% in 2021 and then plummeted by 96.02% in 2025.
  • Quarter analysis of 5 years shows Organon's Accumulated Expenses stood at $1.0 billion in 2021, then grew by 16.36% to $1.2 billion in 2022, then increased by 16.92% to $1.4 billion in 2023, then rose by 1.58% to $1.4 billion in 2024, then rose by 2.34% to $1.4 billion in 2025.
  • Its Accumulated Expenses was $1.4 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.4 billion in Q1 2025.